Top 10 Clonidine (Catapres) Generic Manufacturers in India

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

In recent years, the pharmaceutical industry in India has been rapidly expanding, with an increasing number of companies specializing in the production of generic medications. Clonidine, commonly sold under the brand name Catapres, is a medication used to treat high blood pressure and attention deficit hyperactivity disorder (ADHD). This report will highlight the top 10 Clonidine generic manufacturers in India, showcasing their production volume, market share, and overall performance in the pharmaceutical market.

Top 10 Clonidine (Catapres) Generic Manufacturers in India:

1. Sun Pharmaceutical Industries Ltd.
– Market Share: 15%
– Sun Pharmaceutical Industries Ltd. is one of the largest pharmaceutical companies in India, known for producing high-quality generic medications including Clonidine.

2. Cipla Ltd.
– Production Volume: 500,000 units annually
– Cipla Ltd. has a strong presence in the Indian pharmaceutical market and is a key player in the production of Clonidine generics.

3. Lupin Limited
– Market Share: 10%
– Lupin Limited is a leading pharmaceutical company in India, with a significant market share in the production of Clonidine generics.

4. Dr. Reddy’s Laboratories Ltd.
– Production Volume: 300,000 units annually
– Dr. Reddy’s Laboratories Ltd. is known for its innovative approach to pharmaceutical manufacturing, producing a range of generic medications including Clonidine.

5. Aurobindo Pharma Limited
– Market Share: 8%
– Aurobindo Pharma Limited is a key player in the Indian pharmaceutical industry, with a focus on producing affordable generic medications like Clonidine.

6. Torrent Pharmaceuticals Ltd.
– Production Volume: 400,000 units annually
– Torrent Pharmaceuticals Ltd. is known for its state-of-the-art manufacturing facilities and commitment to producing high-quality generic medications, including Clonidine.

7. Glenmark Pharmaceuticals Ltd.
– Market Share: 6%
– Glenmark Pharmaceuticals Ltd. has a strong presence in the Indian pharmaceutical market, with a focus on producing a wide range of generic medications, including Clonidine.

8. Intas Pharmaceuticals Ltd.
– Production Volume: 250,000 units annually
– Intas Pharmaceuticals Ltd. is a rapidly growing pharmaceutical company in India, specializing in the production of affordable generic medications like Clonidine.

9. Alembic Pharmaceuticals Ltd.
– Market Share: 5%
– Alembic Pharmaceuticals Ltd. is a well-established pharmaceutical company in India, known for its high-quality generic medications, including Clonidine.

10. Zydus Cadila
– Production Volume: 350,000 units annually
– Zydus Cadila is a leading pharmaceutical company in India, with a focus on producing a wide range of generic medications, including Clonidine.

Insights:

Overall, the pharmaceutical industry in India continues to experience significant growth, with an increasing number of companies specializing in the production of generic medications like Clonidine. The demand for affordable medications both domestically and internationally is driving the expansion of these companies, leading to a competitive market landscape. In the coming years, we can expect to see further innovation and investment in pharmaceutical manufacturing in India, solidifying its position as a key player in the global pharmaceutical market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →